The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

As the Trump administration moves to limit COVID booster vaccines for some, here's what to know about the latest variant NB.1 ...

They are getting a major change. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around the vaccine’s ...

The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it ...

In its Friday approval letter, the FDA didn’t explain the restrictions although they reflect skepticism about ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...

Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy ...

That's the same limit that the FDA set in licensing another COVID-19 vaccine option from competitor Novavax. Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines ...

The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula ...

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.